搜索临床试验以:MOD-4023
总计1680个结果
-
OPKO Health, Inc.完全的
-
OPKO Health, Inc.主动,不招人小儿生长激素缺乏症以色列, 美国, 印度, 大韩民国, 澳大利亚, 台湾, 西班牙, 阿根廷, 白俄罗斯, 保加利亚, 加拿大, 哥伦比亚, 乔治亚州, 希腊, 墨西哥, 新西兰, 波兰, 俄罗斯联邦, 乌克兰, 英国
-
OPKO Health, Inc.完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
OPKO Health, Inc.Tel-Aviv Sourasky Medical Center完全的
-
University Hospital Schleswig-Holstein招聘中
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
National Institute on Drug Abuse (NIDA)Technical Resources International, Inc.; Promentis Pharmaceuticals, Inc.; Altasciences Company...尚未招聘
-
M.D. Anderson Cancer CenterReata Pharmaceuticals, Inc.完全的
-
Azura OphthalmicsSyneos Health; Cliantha Research完全的
-
AerasEuropean and Developing Countries Clinical Trials Partnership (EDCTP)完全的
-
Cancer Institute and Hospital, Chinese Academy...Beijing Huanxing Cancer Hospital; Cancer Hospital, Chinese Academy of Medical Sciences, Hebei...招聘中
-
Promentis Pharmaceuticals, Inc.Baylor College of Medicine; Celerion完全的
-
Reata, a wholly owned subsidiary of Biogen终止